The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart Failure

Active, not recruitingOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

July 30, 2023

Primary Completion Date

July 30, 2025

Study Completion Date

October 1, 2025

Conditions
Heart Failure
Trial Locations (1)

11315

Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER